Skip to content
Monday, November 9, 2026
Lunar Betting House

Patients Coming Off Slimming Medications Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

Illustration of medical injection and weighing machine
Obesity treatment involves ongoing approaches.

New research indicates that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds far faster than those who halt traditional diet and exercise regimens.

Published data in a major medical journal demonstrates that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month after stopping.

"Individuals using such medications need to be aware of the danger of rapid weight regain when the treatment is stopped," warns researcher Dr. Susan Jebb.

This pace of regain suggests a reversion to pre-treatment mass within about a year and a half.

Weighing Treatments

The study, which reviewed dozens of studies involving over 9,000 of patients, compared the outcomes of these new drugs with older methods.

Scientists note that people who shed pounds through diet and exercise generally see a more gradual weight regain—approximately 100 grams monthly—after stopping.

The Reason for the Rapid Regain

Experts believe the mode of action of the injections explains the heightened weight return.

The injections imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the body to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making overeating far more likely."

A Chronic Disease?

Medical guidelines recommend the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Many experts say that, due to the high risk of relapse, the treatment should be considered long-term.

This view is supported by drug manufacturers, who say that the findings "emphasize the persistent nature of excess weight," akin to managing conditions like high blood pressure.

Patient Testimonies

Users who have stopped the jabs explain a powerful resurgence of cravings.

"It was like a switch that goes on and I was suddenly starving," described an individual.

This challenge is exacerbated if patients have not developed sustainable dietary or behavioural changes during therapy.

Significant Interest

Recent estimates suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.

  • Use is greater among women compared to males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the drugs through private healthcare rather than the NHS.

In conclusion, researchers caution that while the jabs are potent agents for weight loss, they are not a standalone fix and long-term success hinges on combined behavioural support.

CP
The writer

Colleen Potter

Elara Vance is a seasoned sports analyst with over a decade of experience in statistical modeling and betting strategy development.

Lunar Betting House

Type to search articles.